Lipid-lowering effect of tenofovir in HIV-infected patients

被引：27
|
作者：
Fabbiani, Massimiliano [1 ]
Bracciale, Laura [1 ]
Doino, Maria [1 ]
Sidella, Letizia [1 ]
Farina, Salvatore [1 ]
Di Cristo, Valentina [1 ]
Cauda, Roberto [1 ]
De Luca, Andrea [1 ,2 ]
Di Giambenedetto, Simona [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Ist Clin Malattie Infett, I-00168 Rome, Italy
[2] Siena Univ Hosp, Infect Dis Unit 2, Siena, Italy
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 03期
关键词：
cholesterol; simplification; antiretroviral therapy; cardiovascular risk;
D O I：
10.1093/jac/dkq464
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：682 / 683
页数：2
相关论文
共 50 条
  • [1] Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients
    Gagliardini, Roberta
    Fabbiani, Massimiliano
    Colafigli, Manuela
    D'Avino, Alessandro
    Mondi, Annalisa
    Borghetti, Alberto
    Lamonica, Silvia
    Cauda, Roberto
    De Luca, Andrea
    Di Giambenedetto, Simona
    JOURNAL OF CHEMOTHERAPY, 2017, 29 (05) : 299 - 307
  • [2] Lipid-Lowering Effect and Efficacy After Switching to Etravirine in HIV-Infected Patients With Intolerance to Suppressive HAART
    Casado, Jose L.
    de los Santos, Ignacio
    del Palacio, Maria
    Garcia-Fraile, Lucio
    Perez-Elias, Maria J.
    Sanz, Jesus
    Moreno, Santiago
    HIV CLINICAL TRIALS, 2013, 14 (01): : 1 - 9
  • [3] Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins
    Negredo, Eugenia
    Molto, Jose
    Puig, Jordi
    Cinquegrana, Denise
    Bonjoch, Anna
    Perez-Alvarez, Nuria
    Lopez-Blazquez, Raquel
    Blanco, Asuncion
    Clotet, Bonaventura
    Rey-Joly, Celestino
    AIDS, 2006, 20 (17) : 2159 - 2164
  • [4] Effect of diet on lipid profile in HIV-infected patients
    Jackiewicz, Agata
    Czarnecki, Marcin
    Knysz, Brygida
    HIV & AIDS REVIEW, 2018, 17 (03): : 159 - 163
  • [5] Effectiveness of lipid-lowering therapy in HIV patients
    Martinez, Esteban
    Leyes, Pere
    Ros, Emilio
    CURRENT OPINION IN HIV AND AIDS, 2008, 3 (03) : 240 - 246
  • [6] Real-Life Impact on Lipid Profile of a Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected Patients
    Lagoutte-Renosi, Jennifer
    Flammang, Mylene
    Chirouze, Catherine
    Beck-Wirth, Genevieve
    Bozon, Fabienne
    Brunel, Anne-Sophie
    Drobacheff-Thiebaut, Marie-Christine
    Foltzer, Adeline
    Hustache-Mathieu, Laurent
    Kowalczyk, Jakub
    Michel, Catherine
    Davani, Siamak
    Muret, Patrice
    CURRENT HIV RESEARCH, 2021, 19 (01) : 84 - 89
  • [7] A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia
    Chastain, Lisa M.
    Bain, Amy M.
    Edwards, Krystal L.
    Bedimo, Roger
    Busti, Anthony J.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2007, 1 (06) : 634 - 639
  • [8] Tenofovir Effect on the Kidneys of HIV-Infected Patients: A Double-Edged Sword?
    Tourret, Jerome
    Deray, Gilbert
    Isnard-Bagnis, Corinne
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (10): : 1519 - 1527
  • [9] Effect of fatty acid content in the diet on lipid profile in HIV-infected patients treated with antiretroviral drugs
    Jackiewicz, Agata
    Czarnecki, Marcin
    Przeliorz-Pyszczek, Anna
    Knysz, Brygida
    HIV & AIDS REVIEW, 2019, 18 (01): : 25 - 32
  • [10] Dyslipidemia and lipid management in HIV-infected patients
    Lo, Janet
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2011, 18 (02) : 144 - 147
12345